Antisense Therapeutics Limited (ATHJF)
Antisense Therapeutics Limited has an analyst consensus of Moderate Buy, with a price target consensus of $0.19.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ATHJF:
- Analysts Offer Insights on Industrial Goods Companies: and Nuvve Holding (NVVE)
- Sunnova Energy International (NOVA) Gets a Buy Rating from RBC Capital
- Sunrun (RUN) Gets a Buy Rating from RBC Capital
- Caladrius Biosciences (CLBS) Gets a Buy Rating from Brookline Capital Markets
- 2 Stocks With Insider Trades Worth Paying Attention to